About Kanvas Biosciences
Kanvas Biosciences is a company based in Ithaca (United States) founded in 2021 by Iwijn De Vlaminck and Matthew P Cheng.. Kanvas Biosciences has raised $24.28 million across 2 funding rounds from investors including Germin8, DCVC and Lion Capital. Kanvas Biosciences offers products and services including Spatial Mapping Platform and Live Biotherapeutics Pipeline. Kanvas Biosciences operates in a competitive market with competitors including Moderna, Jazz Pharmaceuticals, BeiGene, Advanced Accelerator Applications and Aclaris Therapeutics, among others.
- Headquarter Ithaca, United States
- Founders Iwijn De Vlaminck, Matthew P Cheng
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$24.28 M (USD)
in 2 rounds
-
Latest Funding Round
$12.5 M (USD), Series A
Mar 04, 2024
-
Investors
Germin8
& 8 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Kanvas Biosciences
Kanvas Biosciences offers a comprehensive portfolio of products and services, including Spatial Mapping Platform and Live Biotherapeutics Pipeline. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Platform for mapping host-microbiome interactions in drug discovery.
Pipeline for microbiome-modulating treatments in health and disease.
Unlock access to complete
Funding Insights of Kanvas Biosciences
Kanvas Biosciences has successfully raised a total of $24.28M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $12.5 million completed in March 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series A — $12.5M
-
First Round
First Round
(13 Jun 2023)
- Investors Count 9
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2024 | Amount | Series A - Kanvas Biosciences | Valuation | DCVC | |
| Jun, 2023 | Amount | Seed - Kanvas Biosciences | Valuation | DCVC |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Kanvas Biosciences
Kanvas Biosciences has secured backing from 9 investors, including venture fund and institutional investors. Prominent investors backing the company include Germin8, DCVC and Lion Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm focused on multiple sectors
|
Founded Year | Domain | Location | |
|
Private equity firm focused on consumer brands
|
Founded Year | Domain | Location | |
|
Investments are focused on innovations in women's health.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Kanvas Biosciences
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Kanvas Biosciences
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Kanvas Biosciences Comparisons
Competitors of Kanvas Biosciences
Kanvas Biosciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Moderna, Jazz Pharmaceuticals, BeiGene, Advanced Accelerator Applications and Aclaris Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
mRNA-based therapeutics for diseases including cancer and infections are developed.
|
|
| domain | founded_year | HQ Location |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| domain | founded_year | HQ Location |
Targeted and immune-oncology drugs for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
Radiopharmaceuticals for oncology diagnostics and therapies are developed and marketed.
|
|
| domain | founded_year | HQ Location |
Novel dermatologic therapies are developed for skin conditions.
|
|
| domain | founded_year | HQ Location |
Small molecules are developed for cancer and skin disease treatments.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Kanvas Biosciences
Frequently Asked Questions about Kanvas Biosciences
When was Kanvas Biosciences founded?
Kanvas Biosciences was founded in 2021 and raised its 1st funding round 2 years after it was founded.
Where is Kanvas Biosciences located?
Kanvas Biosciences is headquartered in Ithaca, United States. It is registered at Ithaca, New York, United States.
Is Kanvas Biosciences a funded company?
Kanvas Biosciences is a funded company, having raised a total of $24.28M across 2 funding rounds to date. The company's 1st funding round was a Seed of $11.78M, raised on Jun 13, 2023.
What does Kanvas Biosciences do?
Kanvas Biosciences was founded in 2021 in Ithaca, United States, as a provider in the biotechnology sector. Solutions focused on imaging for microbial research and infectious diseases are developed and offered. Operations center on advancing tools for scientific applications in these areas. The company is co-founded by Iwijn De Vlaminck and Matthew P Cheng, with activities based in the United States.
Who are the top competitors of Kanvas Biosciences?
Kanvas Biosciences's top competitors include Moderna, Jazz Pharmaceuticals and Advanced Accelerator Applications.
What products or services does Kanvas Biosciences offer?
Kanvas Biosciences offers Spatial Mapping Platform and Live Biotherapeutics Pipeline.
Who are Kanvas Biosciences's investors?
Kanvas Biosciences has 9 investors. Key investors include Germin8, DCVC, Lion Capital, FemHealth Ventures, and Ki Tua Fund.